Home Beyond the Data Series

Beyond the Data: A Column by Dr. Drew Altman

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Americans May Be Smarter About Vaccines Than You Think

In a new column that analyzes recent KFF polling, Founding President and CEO Dr. Drew Altman concludes that only a sliver of the public hold definitive anti-science, anti-vaccine views, and are greatly outnumbered by the people who believe established science, with even more Americans stuck in a “muddled middle.” He writes, “when you see reports of social media engagement spiking about a health myth, don’t overreact. It’s more likely than not that it’s a relatively small group of Americans who already believe it talking to themselves, and they are vastly outnumbered by those who believe the science.”

About KFF

Untold KFF History Volume 2: Kaisernetwork.org

In the second of his “Untold KFF History” series, KFF’s Founding President and CEO Dr. Drew Altman discusses KFF’s first big foray into health news: Kaisernetwork.org, which was an online health policy resource and webcasting service called “HealthCast.”

“We announced KFF’s new mission in March 1991, and from the beginning we had a twin focus on policy and media... But our first foray into directly operating a ‘news’ or news-like organization itself was kasernetwork.org, which began in 2000.”

Untold KFF History Volume 1: South Africa

As KFF approaches a leadership transition next year, Founding President and CEO Dr. Drew Altman will share a series of occasional columns about key moments in the organization’s 37-year history. The first in the series recalls KFF’s (then called the Kaiser Family Foundation) decades-long commitment to South Africa during and after apartheid. Dr. Altman will continue his regular columns about health policy.

The Midterms

The New Ideas Conundrum in Health Policy

Dr. Drew Altman writes about the “conundrum of health policy ideas” facing Democrats searching for new proposals because of competing, and complex, priorities: rebuilding Medicaid and the ACA after trillion-dollar cuts, reconstructing federal health agencies, and tackling underlying health care costs, when candidates want simple ideas they can campaign on and voters want their costs to come down.

A Note on How the War in Iran May Affect Health Care in the Midterms

Dr. Drew Altman, KFF’s President and CEO, discusses the impact of the war in Iran and rising gas prices on voter concerns about health care costs. He writes: “Recently, we saw health care costs rise to the top of the public’s list of economic worries, ahead of food, housing, utility costs and the cost of gas….Expect gas prices to rise and health care costs to fall on the list of affordability worries while the war in Iran lasts, but then to return to the top or near the top when President Trump decides to declare the major hostilities over...”

"It remains to be seen if Republican candidates in close races will want to go head-to-head with Democrats on health care, despite Trump’s urging them to do so. They may feel they have other cards to play, and some will not want to highlight decisions they made to cut Medicaid and double people’s ACA premium payments in a general election."

The Midterms Lurk Behind Every Health Policy Move Now

Dr. Drew Altman discusses how midterm political strategy will shape health policy in 2026, focusing on recent moves by President Trump. He writes: “Democrats start out with a significant advantage on health in the midterms, but rather than cut and run to other issues, Trump wants Republicans to try to erode that advantage where they can.”

View the Latest: Beyond the Data

Filter

List Grid

11 - 20 of 65 Results

  • The Midterms Lurk Behind Every Health Policy Move Now

    From Drew Altman

    In his latest column, President and CEO Dr. Drew Altman discusses how midterm political strategy will shape health policy in 2026, focusing on recent moves by President Trump. He writes: “Democrats start out with a significant advantage on health in the midterms, but rather than cut and run to other issues, Trump wants Republicans to try to erode that advantage where they can.”

  • Our Darwinian Approach to Health Care Costs

    From Drew Altman

    In his latest column, President and CEO Dr. Drew Altman presents his Venn diagram of health care cost problems and shows how, in our fragmented health system, reducing one health cost problem often makes another worse.

  • Trump Has No Health Plan, He Has the Art of the Health Care Deal

    From Drew Altman

    In his first column for the new year, KFF CEO Dr. Drew Altman analyzes President Trump’s “make a deal” approach to health care. He explains that while the president doesn’t have a health reform plan, or even “concepts of a plan,” or a replacement for the ACA, he does have a distinctive set of tactics that features one-off deals with the health care industry that are more like “health policy by transaction.” He writes that…

  • Health Policy in 2026

    From Drew Altman

    In a new column, President and CEO Dr. Drew Altman forecasts eight things to look for in health policy in 2026. “First and foremost,” he writes, “is the role health care affordability will play in the midterms.” And, he notes: “The average cost of a family policy for employers could approach $30,000 and cost sharing and deductibles will rise again after plateauing for several years.”

  • Why We Are Stuck with Prior Authorization Review

    From Drew Altman

    Prior authorization review frustrates patients and physicians, but we likely can’t just eliminate it. In his new column, President and CEO Dr. Drew Altman discusses why, and why the focus is now instead on “doing it smarter.” Altman writes: “A proposal to eliminate prior authorization altogether could be the single most tangible and popular health reform idea a candidate could make. But, in our fragmented health system, with no great way to control costs or…

  • Making KFF Less Mysterious Again

    From Drew Altman

    In one of his occasional columns about “us,” President and CEO, Dr. Drew Altman, addresses how KFF, which combines policy research, polling and journalism in one organization, operates and why we’re called KFF today, addressing occasional confusion about our name, how we work and how to describe KFF.

  • Medicare Beneficiaries Are Not Luddites

    From Drew Altman

    In a new column, President and CEO Dr. Drew Altman discusses new KFF survey data that shows that a surprising share of older adults with Medicare are using health tech regularly, and a solid majority support many of CMS’ goals to make it more widely available. But there are also big income gaps in the use of health tech, and concerns about AI, privacy, and other barriers to rapid and more widespread adoption. “Apparently… a…

  • The Semi-Sad Prospects for Controlling Employer Health Care Costs

    From Drew Altman

    In a commentary on KFF’s 27th employer health benefits survey, President and CEO Dr. Drew Altman discusses the obstacles employers face trying to control their health care costs, and the reasons why they’ve never been meaningful supporters of government cost-containment efforts. He predicts that premium increases expected next year could lead to a new wave of higher deductibles and other forms of cost sharing for the 155 million Americans who rely on employer coverage. Read…

  • How an ACA Premium Spike Will Affect Family Budgets, and Voters

    From Drew Altman

    In his latest column, President and CEO Dr. Drew Altman shows how spiking premiums, which may come if the enhanced ACA tax credits are not extended, will hit people in the context of their family budgets, alongside rising costs for food, housing and utilities. For some families, their new health care costs could far exceed what they pay for food, affecting their economic security and potentially their vote.

  • Explaining the Muddle on ACA Tax Credits

    From Drew Altman

    In his latest column, KFF’s President and CEO Dr. Drew Altman looks at why the issue of extending the enhanced ACA tax credits has languished in Congress without clear direction, despite its importance to the 24 million people who get their coverage in the ACA Marketplaces today and the potentially significant role the issue could play in the midterms if the credits are not extended.